M. Runsio et al., CHANGES IN HUMAN CORONARY SINUS BLOOD-FLOW AND MYOCARDIAL-METABOLISM INDUCED BY VENTRICULAR-FIBRILLATION AND DEFIBRILLATION, Journal of cardiothoracic and vascular anesthesia, 12(1), 1998, pp. 45-50
Citations number
32
Categorie Soggetti
Anesthesiology,"Peripheal Vascular Diseas","Cardiac & Cardiovascular System
Background: During implantation of cardioverter-defibrillators,repeate
d inductions of ventricular fibrillation and defibrillation are perfor
med. Little is known about the myocardial metabolism associated with v
entricular fibrillation and defibrillation in humans. Methods:Sixteen
patients scheduled for transvenous cardioverter-defibrillator implanta
tion were included in the study. In 10 of the patients, blood samples
were taken simultaneously in the coronary sinus and radial artery and
analyzed for PO2, PCO2, standard bicarbonate, pH, lactate, alanine, gl
ucose, and glycerol. Oxygen saturation, base excess, and oxygen conten
t were calculated. The patients were studied before, shortly after, an
d 2 and 5 minutes after successful defibrillation. In six of the patie
nts, coronary sinus blood flow was registered continuously. Results: T
he coronary sinus blood flow declined from a basal value of 93 +/- 16
mL/min to 35 +/- 6 mL/min 14 +/- 2 seconds after induction of ventricu
lar fibrillation. Following termination of ventricular fibrillation, c
oronary sinus blood flow increased to a peak value of 227 +/- 75 mL/mi
n. Oxygen saturation, PO2, and oxygen content in the coronary sinus in
creased by approximately 25% shortly after each episode of ventricular
fibrillation and defibrillation. The coronary sinus lactate increased
and the arterio-coronary sinus lactate difference decreased shortly a
fter each of the four episodes, but was normalized within 2 minutes. C
onclusions: Repeated threshold tests during defibrillator implantation
did not cause any long-lasting or cumulative metabolic effects, indic
ating that the described technique, with a 5-minute recovery period in
between episodes, is safe as regards myocardial metabolism. Copyright
(C) 1998 by W.B. Saunders Company.